Back to today’s briefing

Story perspectives

Propranolol Reduces Stroke Risk by 52% for Women

1/30/2025

49 12

Summary

Story summary

A groundbreaking study from Vanderbilt University reveals that propranolol, a beta blocker, can slash ischemic stroke risk by an impressive 52% in women suffering from migraines, while showing no benefits for men. This research, which examined over 3 million medical records, underscores the urgent need for accessible migraine treatments, particularly for women in underserved communities.

1 of 1

Story summary

A groundbreaking study from Vanderbilt University reveals that propranolol, a beta blocker, can slash ischemic stroke risk by an impressive 52% in women suffering from migraines, while showing no benefits for men. This research, which examined over 3 million medical records, underscores the urgent need for accessible migraine treatments, particularly for women in underserved communities.